Identification of Potential Molecular Targets and Active Ingredients of Mingmu Dihuang Pill for the Treatment of Diabetic Retinopathy Based on Network Pharmacology

Figure 7

Molecular docking of active compounds of Mingmu Dihuang pill with AKT1, SRC, and VEGFA proteins. The red indicates small-molecule ligands and the green indicates amino acid residues of receptors. (a) AKT1-luteolin; (b) AKT1-acacetin; (c) SRC-alisol B; (d) SRC-acacetin; (e) VEGFA-alisol B; (f) VEGFA-luteolin.

(a)

(b)

(c)

(d)

(e)

(f)